Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Juan Cheng, Jing Chen, Bei Xie & Hu-lai Wei. (2013) Acquired multidrug resistance in human K562/ADM cells is associated with enhanced autophagy. Toxicology Mechanisms and Methods 23:9, pages 678-683.
Read now
Read now
Omar Al Ustwani & Meir Wetzler. (2013) Homoharringtonine and granulocyte colony-stimulating factor priming for acute myeloid leukemia: is it ready for prime time?. Leukemia & Lymphoma 54:10, pages 2100-2102.
Read now
Read now
Theo Daniel Kim, Mareike Frick & Philipp le Coutre. (2011) Omacetaxine mepesuccinate for the treatment of leukemia. Expert Opinion on Pharmacotherapy 12:15, pages 2381-2392.
Read now
Read now
Luize Otero, Bruno Terra, Cláudia Diniz, Eliana Abdelhay & Teresa De Souza Fernandez. (2009) Dicentric t(8;13)(q10;q10) as an additional chromosomal abnormality in a case of acute promyelocytic leukemia with very poor outcome. Leukemia & Lymphoma 50:2, pages 287-289.
Read now
Read now
Articles from other publishers (20)
Lei Shang, Xiaojin Cai, Wanchen Sun, Qingnian Cheng & Yingchang Mi. (2021)
Time point‐dependent concordance and prognostic significance of flow cytometry and real time quantitative
PCR
for measurable/minimal residual disease detection in acute myeloid leukemia with t(8;21)(q22;q22.1)
. Cytometry Part B: Clinical Cytometry 102:1, pages 34-43.
Crossref
Crossref
Chinadol Wanitpongpun, Eakkapol Utchariyaprasit, Weerapat Owattanapanich, Adisak Tantiworawit, Ekarat Rattarittamrong, Pimjai Niparuck, Teeraya Puavilai, Jakrawadee Julamanee, Pirun Saelue, Chantiya Chanswangphuwana, Chantana Polprasert, Chajchawan Nakhakes, Wasithep Limvorapitak, Nonglak Kanitsap, Kannadit Prayongratana & Chantrapa Sriswasdi. (2021) Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG). Clinical Lymphoma Myeloma and Leukemia 21:7, pages e635-e643.
Crossref
Crossref
Doudou Yan, Hui Wei, Xinning Lai, Yangyang Ge, Shilin Xu, Jie Meng, Tao Wen, Jian Liu, Weiqi Zhang, Jianxiang Wang & Haiyan Xu. (2020) Co-delivery of homoharringtonine and doxorubicin boosts therapeutic efficacy of refractory acute myeloid leukemia. Journal of Controlled Release 327, pages 766-778.
Crossref
Crossref
Hui Wei, Ying Wang, Robert Peter Gale, Dong Lin, Chunlin Zhou, Bingcheng Liu, Shaowei Qiu, Runxia Gu, Yan Li, Xingli Zhao, Shuning Wei, Benfa Gong, Kaiqi Liu, Xiaoyuan Gong, Yuntao Liu, Guangji Zhang, Zhen Song, Yang Wang, Wei Li, Yingchang Mi & Jianxiang Wang. (2020) Randomized Trial of Intermediate-dose Cytarabine in Induction and Consolidation Therapy in Adults with Acute Myeloid Leukemia. Clinical Cancer Research 26:13, pages 3154-3161.
Crossref
Crossref
Can Chen, Xilian Huang, Kaile Wang, Kuang Chen, Danquan Gao & Shenxian Qian. (2018) Early mortality in acute promyelocytic leukemia: Potential predictors (Review). Oncology Letters.
Crossref
Crossref
Q. Zhang, Q. Zhang, Q. Li, B. Liu, Y. Wang, D. Lin, C. Zhou, W. Li, K. Tang, Z. Tian, M. Wang, J. Wang & Y. Mi. (2014)
Monitoring of
WT
1 and its target gene
IRF
8 expression in acute myeloid leukemia and their significance
. International Journal of Laboratory Hematology 37:4.
Crossref
Crossref
Ying Wang, Dong Lin, Hui Wei, Wei Li, Bingcheng Liu, Chunlin Zhou, Kaiqi Liu, Yingchang Mi & Jianxiang Wang. (2015) Long-term follow-up of homoharringtonine plus all-trans retinoic acid-based induction and consolidation therapy in newly diagnosed acute promyelocytic leukemia. International Journal of Hematology 101:3, pages 279-285.
Crossref
Crossref
Hagop Kantarjian, Susan O'Brien, Elias Jabbour, Gisoo Barnes, Ashutosh Pathak & Jorge Cortes. (2015) Effectiveness of Homoharringtonine (Omacetaxine Mepesuccinate) for Treatment of Acute Myeloid Leukemia: A Meta-Analysis of Chinese Studies. Clinical Lymphoma Myeloma and Leukemia 15:1, pages 13-21.
Crossref
Crossref
Jie Jin, Jian-Xiang Wang, Fei-Fei Chen, De-Pei Wu, Jiong Hu, Jian-Feng Zhou, Jian-Da Hu, Jian-Min Wang, Jian-Yong Li, Xiao-Jun Huang, Jun Ma, Chun-Yan Ji, Xiao-Ping Xu, Kang Yu, Han-Yun Ren, Yu-Hong Zhou, Yin Tong, Yin-Jun Lou, Wan-Mao Ni, Hong-Yan Tong, Hua-Feng Wang, Ying-Chang Mi, Xin Du, Bao-An Chen, Yi Shen, Zhu Chen & Sai-Juan Chen. (2013) Homoharringtonine-based induction regimens for patients with de-novo acute myeloid leukaemia: a multicentre, open-label, randomised, controlled phase 3 trial. The Lancet Oncology 14:7, pages 599-608.
Crossref
Crossref
Lixia Zhang, Qinghua Li, Wei Li, Bingcheng Liu, Ying Wang, Dong Lin, Chunlin Zhou, Chengwen Li, Jianxiang Wang & Yingchang Mi. (2013) Monitoring of minimal residual disease in acute myeloid leukemia with t(8;21)(q22;q22). International Journal of Hematology 97:6, pages 786-792.
Crossref
Crossref
Di Wang, Chun Qiao, Min Xiao, Zhe Geng, Zhen Shang, Jing He, Mei Huang, Yang Yang, Na Zhang, Yanan Liu, Jianyong Li, Chunrui Li & Jianfeng Zhou. (2012) Integrative analysis of prognostic factors in Chinese core binding factor leukemia. Biochemical and Biophysical Research Communications 428:3, pages 411-415.
Crossref
Crossref
Elenice Ferreira Bastos, Lidiane Alice Silva, Marcelo Coelho Ramos, Glicínia Pimenta, Paulo Ivo Cortez, Stella Beatriz Gonçalves de Lucena & Teresa de Souza Fernandez. (2012) Trisomy 11 as an Additional Chromosome Alteration in a Child with Acute Promyelocytic Leukemia with Poor Prognosis. Case Reports in Genetics 2012, pages 1-4.
Crossref
Crossref
Bei Liu, Li Zhao, HaiZhen Ma, Wei Zhang & Yu Jin. (2011) Knockdown of MRP4 by lentivirus-mediated siRNA improves sensitivity to adriamycin in adriamycin-resistant acute myeloid leukemia cells. Chinese Science Bulletin 57:1, pages 90-97.
Crossref
Crossref
Xiaojuan Chen, Wenyu Yang & Xiaofan Zhu. (2011) Successful treatment of childhood Philadelphia chromosome-positive acute myeloid leukemia. Pediatrics International 53:4, pages 598-600.
Crossref
Crossref
Lei Zhi, Min Wang, Qing Rao, Fan Yu, Yingchang Mi & Jianxiang Wang. (2010) Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38−/CD123+ leukemic stem cells by chemotherapy-resistance. Cancer Letters 296:1, pages 65-73.
Crossref
Crossref
Y Ma, X Wang, X Xu & G Lin. (2009) World Health Organization Sub-Types, Initial Treatment Outcome and Prognostic Study of Unselected Adult Patients with Acute Myeloid Leukaemia in Shanghai: An Analysis of 623 Cases. Journal of International Medical Research 37:4, pages 1191-1201.
Crossref
Crossref
Jie Xiao, Songmei Yin, Yiqing Li, Shuangfeng Xie, Danian Nie, Liping Ma, Xiuju Wang, Yudan Wu & Jianhong Feng. (2009) SKP2 siRNA inhibits the degradation of P27<sup>kip1</sup> and down-regulates the expression of MRP in HL-60/A cells. Acta Biochimica et Biophysica Sinica 41:8, pages 699-708.
Crossref
Crossref
Jiazhuo Liu, Yingchang Mi, Mingwei Fu, Wenjuan Yu, Ying Wang, Dong Lin, Shougeng Bian & Jianxiang Wang. (2009) Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia. American Journal of Hematology 84:7, pages 422-427.
Crossref
Crossref
E Ortiz-Sánchez, T R Daniels, G Helguera, O Martinez-Maza, B Bonavida,M L Penichet. (2008) Enhanced cytotoxicity of an anti-transferrin receptor IgG3-avidin fusion protein in combination with gambogic acid against human malignant hematopoietic cells: functional relevance of iron, the receptor, and reactive oxygen species. Leukemia 23:1, pages 59-70.
Crossref
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:3, pages 184-191.
Crossref
Crossref